Compounds and methods for treatment of HCV
Details for Australian Patent Application No. 2007313250 (hide)
International Classifications
Event Publications
21 May 2009 PCT application entered the National Phase
PCT publication WO2008/048589 Priority application(s): WO2008/048589
15 October 2009 Amendment Made
The nature of the amendment is: Amend the name of the inventors add co-inventor Liu, Yixin and correct co-inventor from Wobbe, C. Richard to Wobbe, Richard C.
10 December 2009 Amendment Made
The nature of the amendment is: Amend the name of the co-inventor from Ruoqiu, Wu to Wu, Ruoqiu
10 December 2009 Corrigenda
Amendments - Amendments Made Under the name XTL Biopharmaceuticals Ltd, Application No. 2007313250, under INID (72) correct the co-inventor name to Wobbe, C. Richard Corrigenda
28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007313251-Stable offset emulsion inks containing non-water soluble polymeric surfactants
2007313216-Minimally invasive tooling for delivery of interspinous spacer
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser